Crohn’s disease

Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
Five ways care management can shift to value-based careAs fee-for-service rapidly transforms into value-based care, the industry must improve member engagement and outcomes by using targeted care management interventions that help deliver bottom-line results across a broader spectrum of the population.
Genetic testing raises difficult questions for payersA new database helps payers understand which genetic tests are available, which genes they test for, and which tests would be appropriate to use to inform patient management.